Other Stories

S. Korea reports 121 new COVID-19 cases on Thursday Updated: 2020-10-23 05:55:51 KST

South Korea on Thursday reported 121 new COVID-19 cases.
According to the Korea Disease Control and Prevention Agency, 104 cases were domestic infections the first time locally transmitted cases have gone above a hundred since September 24th.
The other 17 cases were from overseas.
This brings the total number of coronavirus infections across the nation to over 25,500.

Thursday's figure is the second time the daily figures have exceeded a hundred since the country eased its social distancing measures last week.
On October 12th, social distancing guidelines were revised to level one, the lowest level in the three-tier system following a downward trend in cases.

However, there have still been cluster infections in recent weeks, mainly at nursing homes and long-term care hospitals.
As of Thursday, a total of 106 cases are linked to a rehabilitation hospital in Gwangju, Gyeonggi-do Province, while 84 others are tied to a nursing home in Busan.

Starting Monday, the country is conducting tests on those related to such risk-prone facilities in the greater Seoul area to contain the spread of the virus.

"On October 19th and 20th, the Seoul Metropolitan Government conducted tests on two,746 workers at 30 medical facilities in the capital. Among those, only one tested positive. Testing and tracing are being carried out at the long-term care hospital in Yeongdeungpo-gu District."

Meanwhile, South Korean biopharmaceutical company Green Cross Pharma has agreed to work with an international organization to manufacture COVID-19 vaccines for global distribution.
Under the deal with the Coalition for Epidemic Preparedness Innovations, Green Cross Pharma plans to produce 500 million doses of COVID-19 vaccines between March 2021 and May 2022.
The agreement aims to accelerate the production of vaccines worldwide and to ensure fair and equitable access to the vaccine.
Min Suk-hyen, Arirang News.
KOGL : Korea Open Government License
본 저작물 중 본문에 해당하는 뉴스 스크립트(텍스트)는 공공누리 제1유형-출처표시 조건에 따라 이용할 수 있습니다.